Previous Close | 14.27 |
Open | 14.26 |
Bid | 13.71 x 1000 |
Ask | 14.56 x 1000 |
Day's Range | 14.08 - 14.28 |
52 Week Range | 11.34 - 14.37 |
Volume | |
Avg. Volume | 85,512 |
Market Cap | 385.642M |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | 17.85 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.33 (9.43%) |
Ex-Dividend Date | Feb 21, 2024 |
1y Target Est | N/A |
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 /abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" ...
PHILADELPHIA, PA / ACCESSWIRE / March 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ, THW) (NYSE American:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in ...
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") ...